BOSTON —The world’s most valuable drugmaker is finally opening its doors in the country’s biggest biotech hub.
Eli Lilly officially opened its gleaming new 12-story research center in Boston on Tuesday. The $700 million facility, first announced in 2022, will ultimately accommodate 700 people, mostly scientists working on some of the company’s earliest drug discovery programs.
The building was originally billed as the Lilly Institute for Genetic Medicine but is now called the Lilly Seaport Innovation Center. A company spokesperson told Endpoints News that the genetic medicines group is housed in the building and is still the primary focus of the center, but that researchers working on other kinds of drugs will also share the space.
“There are more than 400 million people living with genetic disease worldwide,” chief scientific officer Dan Skovronsky said at the event. The company began focusing on genetic medicines in 2018.
“With a lot of
